Edesa Biotech is trading at $5.44 (+5.29%) in after-hours trading in what appears to be a thin-liquidity rebound following a regular session close of $5.17.
- There have been no new earnings, SEC filings, or material headlines released to explain the upward move.
- The price action is likely driven by extended-hours volatility and light trading flow rather than company-specific news.